McKesson Corporation $MCK Shares Sold by Arizona State Retirement System

Key Points

• Arizona State Retirement System trimmed its McKesson stake by 3.5% in Q4, selling 1,266 shares and now holds 35,293 shares valued at about $28.95 million.
• Insiders sold shares — executives disposed of 3,592 shares in the quarter (EVP Michele Lau sold 2,725 shares at roughly $990), leaving insiders with 0.08% ownership.
• Financials and outlook: McKesson beat Q results (EPS $9.34 vs. $9.19, revenue $106.16B, +11.4% YoY), set FY2026 EPS guidance of 38.8–39.2, and holds a MarketBeat consensus rating of "Moderate Buy" with a ~$972.27 price target.

Arizona State Retirement System decreased its holdings in shares of McKesson Corporation (NYSE:MCK - Free Report) by 3.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,293 shares of the company's stock after selling 1,266 shares during the quarter. Arizona State Retirement System's holdings in McKesson were worth $28,950,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Diversified Enterprises LLC acquired a new position in shares of McKesson during the 4th quarter valued at $288,000. Chicago Partners Investment Group LLC lifted its holdings in shares of McKesson by 19.4% during the 4th quarter. Chicago Partners Investment Group LLC now owns 1,225 shares of the company's stock valued at $1,005,000 after acquiring an additional 199 shares in the last quarter. Quent Long Short Global Small Cap Fund LP acquired a new position in shares of McKesson during the 4th quarter valued at $937,000. Turtle Creek Wealth Advisors LLC lifted its holdings in shares of McKesson by 13.4% during the 4th quarter. Turtle Creek Wealth Advisors LLC now owns 772 shares of the company's stock valued at $633,000 after acquiring an additional 91 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. AG lifted its holdings in shares of McKesson by 135.1% during the 4th quarter. B. Metzler seel. Sohn & Co. AG now owns 16,126 shares of the company's stock valued at $13,245,000 after acquiring an additional 9,266 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company's stock.

Insiders Place Their Bets

In other McKesson news, EVP Michele Lau sold 2,725 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the transaction, the executive vice president directly owned 3,247 shares of the company's stock, valued at $3,214,530. This represents a 45.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company's stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 3,592 shares of company stock valued at $3,518,555. Company insiders own 0.08% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on MCK shares. Raymond James Financial set a $970.00 target price on shares of McKesson in a report on Thursday, March 5th. Robert W. Baird set a $968.00 target price on shares of McKesson in a report on Wednesday, January 14th. Wall Street Zen cut shares of McKesson from a "buy" rating to a "hold" rating in a research report on Saturday, April 11th. TD Cowen boosted their target price on shares of McKesson from $1,000.00 to $1,012.00 and gave the stock a "buy" rating in a research report on Thursday, February 5th. Finally, Bank of America reduced their target price on shares of McKesson from $1,040.00 to $1,000.00 and set a "buy" rating on the stock in a research report on Monday, April 6th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $972.27.

McKesson Stock Up 0.8%

Shares of MCK opened at $835.97 on Friday. The business's 50 day moving average is $906.22 and its two-hundred day moving average is $856.65. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The firm has a market cap of $102.40 billion, a price-to-earnings ratio of 24.04, a PEG ratio of 1.20 and a beta of 0.42.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period in the prior year, the company posted $8.03 EPS. McKesson's quarterly revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts expect that McKesson Corporation will post 39.02 earnings per share for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 1st. Shareholders of record on Monday, June 1st will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson's dividend payout ratio is presently 9.43%.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.